Negative regulation of the Wnt-β-catenin pathway by the transcriptional repressor HBP1

EMBO Journal

Volumn 20, Issue 16, 2001, Pages 4500-4511

  Sampson, Ellen M ^a   Haque, Zaffar K ^a   Ku, Man Ching ^a   Tevosian, Sergei G ^a,b   Albanese, Chris ^c   Pestell, Richard G ^c   Paulson, K Eric ^a   Yee, Amy S ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Catenin; HBP1; HMG box transcription factor; Wnt

Indexed keywords

AXIN; BETA CATENIN; CYCLIN D1; LYMPHOID ENHANCER FACTOR 1; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DNA BINDING; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATOR GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BETA CATENIN; CACO-2 CELLS; CELL LINE, TRANSFORMED; CYCLIN D1; CYTOSKELETAL PROTEINS; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; GROWTH INHIBITORS; HIGH MOBILITY GROUP PROTEINS; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; WNT PROTEINS; ZEBRAFISH PROTEINS;

ANIMALIA; MAMMALIA;

EID: 0035881837     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/20.16.4500     Document Type: Article

References (48)

1. Transforming p21 ras mutants and ets2 activate the cyclin D1 promoter through distinguishable regions
2. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium
3. The yin-yang of TCF/β-catenin signaling
4. Genetic alteration mapping on chromosome 7 in primary breast cancer
5. TCF: Transcriptional activator or repressor
6. Linking colorectal cancer to Wnt signaling
7. β-catenin-histone deacetylase interactions regulate the transition of LEF1 from a transcriptional repressor to an activator
8. A common human skin tumour is caused by activating mutations in β-catenin
9. Wnt signaling to β-catenin involves two interactive components Glycogen synthase kinase-3 β inhibition and activation of protein kinase C
10. Location of several putative genes possibly involved in human breast cancer progression
11. Regulation of LEF-1/TCF transcription factors by Wnt and other signals
12. Identification of c-myc as a target of the APC pathway
13. Mechanisms of cyclin D1 (CCN1 PRAD1) overexpression in human cancer: Analysis of allele-specific expression
14. β-catenin-sensitive isoforms of lymphoid enhancer factor-1 are selectively expressed in colon cancer
15. Modulation of transcriptional regulation by LEF-1 in response to Wnt-1 signaling and association with β-catenin
16. The TAKI-NLK-MAPK-related pathway antagonizes signalling between β-catenin and transcription factor TCF
17. Allelotyping of acute myelogenous leukemia: Loss of heterozygosity at 7q31.1 (D7S486) and q33-q34 (D7S498, D7S505)
18. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/colon carcinoma
19. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4
20. The HMG-box transcription factor HBP1 is targeted by the pocket proteins and E1A
21. Involvement of retinoblastoma protein and HBP1 in histone H1(0) gene expression
22. Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer
23. Molecular anatomy of chromosome 7q deletions in myeloid neoplasms: Evidence for multiple critical loci
24. Cloning and expression of human HBP1, a high mobility group protein that enhances myeloperoxidase (MPO) promoter activity
25. β-catenin, a novel prognostic marker for breast cancer: Its roles in cyclin D1 expression and cancer progression
26. Structural basis for DNA bending by the architectural transcription factor Lef-1
27. MAP kinase and Wnt pathways converge to downregulate an HMG-domain repressor in Caenorhabditis elegans
28. β-catenin signaling and cancer
29. Activation of β-catenin-TCF signalling in colon cancer by mutations in B-catenin or APC
30. Wnt targets: Repression and activation
31. Wnt signaling and cancer
32. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1
33. AXIN1 mutations in hepatocellular carcinomas and growth suppression in cancer cells by virus-mediated transfer of AXIN1
34. Regulation of differentiation by HBP1, a target of the retinoblastoma protein
35. HMG box transcriptional repressor HPB maintains a proliferation barrier in differentiated liver tissue
36. The cyclin D1 gene is a target of the B-catenin/LEF pathway
37. B-catenin regulates expression of cyclin D1 in colon carcinoma cells
38. HBP-I: A new transcriptional repressor that is targeted by the retinoblastoma family
39. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice
40. An HMG-box-containing T-cell factor required for thymocyte differentiation
41. Drosophila CBP represses the transcription factor TCF to antagonize Wingless signalling
42. Inhibition of cyclin D1 kinase activity is associated with E2F-mediated inhibition of cyclin D1 promoter activity through E2F and Spl
43. Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinoma from non-malignant lesions
44. (C-A)n microsatellite repeat D7S522 is the most commonly deleted region in human primary breast cancer
45. Frequent loss of heterozygosity in human primary squamous cell and colon carcinomas at 7q31.1: Evidence for a broad range tumor suppressor gene
46. Allelic loss at 7q31.1 in human primary ovarian carcinomas suggests the existence of a tumor suppressor gene
47. Human HMG box transcription factor HBP1: A role in hCD2 LCR function
48. Regulation of Wnt signaling by Sox proteins: XSox17 α/β and XSox3 physically interact with β-catenin